LFVN Lifevantage

LifeVantage to Announce Third Quarter Fiscal Year 2019 Results on May 1, 2019

LifeVantage to Announce Third Quarter Fiscal Year 2019 Results on May 1, 2019

SALT LAKE CITY, April 17, 2019 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its third quarter ended March 31, 2019, after the stock market closes on Wednesday, May 1, 2019. The Company will hold a conference call for investors at 2:30 p.m. Mountain Standard Time (4:30 p.m. Eastern Standard Time) that same day.

Investors interested in participating in the live call can dial (888) 394-8218 from the U.S. or international callers can dial (323) 701-0225. A telephone replay will be available approximately two hours after the call concludes and will be available through Wednesday, May 8, 2019, by dialing (844) 512-2921 from the U.S. and entering confirmation code 3897546, or (412) 317-6671 from international locations, and entering confirmation code 3897546.

There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at . The webcast will be archived for approximately 30 days.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The company is engaged in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin and hair care products, including Protandim®, a line of scientifically-validated dietary supplements; TrueScience®, a line of Nrf2 infused skin care and hair care products; Petandim™ for Dogs, a companion pet supplement formulated to combat oxidative stress in dogs; Axio® Smart Energy Drink mixes; PhysIQ™, a Smart Weight Management System; and Omega+, a 3-in-1 fish oil supplement. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit

Investor Relations Contact:

Scott Van Winkle

Managing Director, ICR

(617) 956-6736

EN
17/04/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lifevantage

 PRESS RELEASE

LifeVantage Declares Quarterly Dividend

LifeVantage Declares Quarterly Dividend SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid March 16, 2026 to all stockholders of record at the close of business on March 2, 2026. About LifeVantage Corporation LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer...

 PRESS RELEASE

LifeVantage Announces Planned Retirement of Steve Fife and CEO Success...

LifeVantage Announces Planned Retirement of Steve Fife and CEO Succession Plan SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, today announced that after nine years at LifeVantage, Steve Fife, President, Chief Executive Officer and a member of the Board of Directors (the “Board”), has decided to retire in April, 2026. Fife will continue in his role as President and Chief Executive Officer during the transition period to ensure business continuity through his re...

 PRESS RELEASE

LifeVantage Announces Financial Results for the Second Quarter of Fisc...

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2026 Announces New $60 Million Share Repurchase Authorization SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2025. Second Quarter Fiscal 2026 Summary*: Revenue was $48.9 million, a decrease of 27.8% from the prior year period. Revenue was up 2.9% sequentially from the fir...

 PRESS RELEASE

LifeVantage to Announce Second Quarter Fiscal Year 2026 Results on Feb...

LifeVantage to Announce Second Quarter Fiscal Year 2026 Results on February 4, 2026 SALT LAKE CITY, Jan. 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its second quarter ended December 31, 2025, after the stock market closes on Wednesday, February 4, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors inter...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch